Immunomedics Reaches Analyst Target Price By: ETF Channel October 05, 2017 at 09:35 AM EDT In recent trading, shares of Immunomedics, Inc. (IMMU) have crossed above the average analyst 12-month target price of $13.50, changing hands for $13.53/share.. Read More >> Related Stocks: Immunomedics Inc